Incyte (INCY) Short term Debt (2012 - 2026)
Incyte (INCY) posted Short term Debt of $39.4 million for Q1 2026, down 4.28% on a QoQ basis from $41.1 million in Q4 2025, and down 5.59% year-over-year from $41.7 million in Q1 2025.
Incyte (INCY) Short term Debt (2012 - 2026) Analysis & Trends
Incyte's Short term Debt history runs 14 years deep, the most recent figure standing at $39.4 million for Q1 2026.
- Quarterly Short term Debt fell 5.59% year-over-year to $39.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39.4 million (down 5.59% YoY) and the FY2025 annual result came in at $41.1 million, up 4.86% from the prior year.
- Short term Debt was $39.4 million for Q1 2026 at Incyte, down from $41.1 million in the prior quarter.
- Across five years, Short term Debt topped out at $46.8 million in Q2 2025 and bottomed at $34.2 million in Q3 2022.
- A 5-year average of $39.1 million and a median of $37.9 million in 2022 frame the typical range for Short term Debt.
- Annual changes were most pronounced in 2022 — Short term Debt dropped 10.55% — and 2025, when it increased 26.07%.
- Incyte's Short term Debt stood at $36.5 million in 2022, then gained by 5.16% to $38.4 million in 2023, then gained by 2.12% to $39.2 million in 2024, then grew by 4.86% to $41.1 million in 2025, then fell by 4.28% to $39.4 million in 2026.
- Business Quant data shows INCY's Short term Debt at $39.4 million in Q1 2026, $41.1 million in Q4 2025, and $45.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Incyte | 23.33 Bn | 19.32 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.38 Mn |
| Dec 31, 2025 | 41.14 Mn |
| Sep 30, 2025 | 45.62 Mn |
| Jun 30, 2025 | 46.84 Mn |
| Mar 31, 2025 | 41.72 Mn |
| Dec 31, 2024 | 39.24 Mn |
| Sep 30, 2024 | 40.34 Mn |
| Jun 30, 2024 | 37.16 Mn |
| Mar 31, 2024 | 37.16 Mn |
| Dec 31, 2023 | 38.42 Mn |
| Sep 30, 2023 | 36.82 Mn |
| Jun 30, 2023 | 37.51 Mn |
| Mar 31, 2023 | 37.17 Mn |
| Dec 31, 2022 | 36.54 Mn |
| Sep 30, 2022 | 34.19 Mn |
| Jun 30, 2022 | 36.92 Mn |
| Mar 31, 2022 | 37.87 Mn |
| Dec 31, 2021 | 37.01 Mn |
| Sep 30, 2021 | 38.22 Mn |
| Jun 30, 2021 | 39.99 Mn |